{"id":"https://openalex.org/W4402436638","doi":"https://doi.org/10.1016/j.toxrep.2024.101732","title":"An overview of immune checkpoint inhibitor toxicities in bladder cancer","display_name":"An overview of immune checkpoint inhibitor toxicities in bladder cancer","publication_year":2024,"publication_date":"2024-09-11","ids":{"openalex":"https://openalex.org/W4402436638","doi":"https://doi.org/10.1016/j.toxrep.2024.101732","pmid":"https://pubmed.ncbi.nlm.nih.gov/39318722","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11420502"},"language":"en","primary_location":{"id":"doi:10.1016/j.toxrep.2024.101732","doi":"https://doi.org/10.1016/j.toxrep.2024.101732","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.toxrep.2024.101732","pdf_url":null,"source":{"id":"https://openalex.org/S2764757124","display_name":"Toxicology Reports","issn_l":"2214-7500","issn":["2214-7500"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology Reports","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.toxrep.2024.101732","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107125920","display_name":"Avenie Mavadia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Avenie Mavadia","raw_affiliation_strings":["GKT School of Medicine, King's College London,\u00a0London SE1 9RT,\u00a0UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GKT School of Medicine, King's College London,\u00a0London SE1 9RT,\u00a0UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059655914","display_name":"Sunyoung Choi","orcid":"https://orcid.org/0009-0008-5913-1036","observed_orcids":["https://orcid.org/0009-0008-5913-1036"]},"institutions":[{"id":"https://openalex.org/I312843336","display_name":"Hampshire Hospitals NHS Foundation Trust","ror":"https://ror.org/04shzs249","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I312843336"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sunyoung Choi","raw_affiliation_strings":["Hampshire Hospitals NHS Foundation Trust,\u00a0Aldermaston Road, Basingstoke,\u00a0Hampshire RG24 9NA,\u00a0UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hampshire Hospitals NHS Foundation Trust,\u00a0Aldermaston Road, Basingstoke,\u00a0Hampshire RG24 9NA,\u00a0UK","institution_ids":["https://openalex.org/I312843336"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064056229","display_name":"Ayden Ismail","orcid":"https://orcid.org/0000-0001-5458-4812","observed_orcids":["https://orcid.org/0000-0001-5458-4812"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ayden Ismail","raw_affiliation_strings":["GKT School of Medicine, King's College London,\u00a0London SE1 9RT,\u00a0UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GKT School of Medicine, King's College London,\u00a0London SE1 9RT,\u00a0UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084117294","display_name":"Aruni Ghose","orcid":"https://orcid.org/0000-0001-8332-8033","observed_orcids":["https://orcid.org/0000-0001-8332-8033"]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]},{"id":"https://openalex.org/I2801222929","display_name":"European CanCer Organisation","ror":"https://ror.org/024e9aw38","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I2801222929"]},{"id":"https://openalex.org/I4210104168","display_name":"Medway NHS Foundation Trust","ror":"https://ror.org/01apxt611","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104168"]},{"id":"https://openalex.org/I4210108939","display_name":"Mount Vernon Cancer Centre","ror":"https://ror.org/01wwv4x50","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210108939","https://openalex.org/I4210122718"]}],"countries":["BE","GB"],"is_corresponding":false,"raw_author_name":"Aruni Ghose","raw_affiliation_strings":["Department of Medical Oncology, Barts Cancer Centre, St Bartholomew's Hospital, Barts Heath NHS Trust,\u00a0London EC1A 7BE,\u00a0UK","Department of Medical Oncology, Medway NHS Foundation Trust,\u00a0Windmill Road,\u00a0Gillingham ME7 5NY,\u00a0UK","Department of Medical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire Trust,\u00a0London HA6 2RN,\u00a0UK","Health Systems and Treatment Optimisation Network, European Cancer Organisation,\u00a0Brussels 1040,\u00a0Belgium","Immuno-Oncology Clinical Network,\u00a0Liverpool,\u00a0UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Barts Cancer Centre, St Bartholomew's Hospital, Barts Heath NHS Trust,\u00a0London EC1A 7BE,\u00a0UK","institution_ids":["https://openalex.org/I1307195382"]},{"raw_affiliation_string":"Department of Medical Oncology, Medway NHS Foundation Trust,\u00a0Windmill Road,\u00a0Gillingham ME7 5NY,\u00a0UK","institution_ids":["https://openalex.org/I4210104168"]},{"raw_affiliation_string":"Department of Medical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire Trust,\u00a0London HA6 2RN,\u00a0UK","institution_ids":["https://openalex.org/I4210108939"]},{"raw_affiliation_string":"Health Systems and Treatment Optimisation Network, European Cancer Organisation,\u00a0Brussels 1040,\u00a0Belgium","institution_ids":["https://openalex.org/I2801222929"]},{"raw_affiliation_string":"Immuno-Oncology Clinical Network,\u00a0Liverpool,\u00a0UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015680235","display_name":"Joecelyn Kirani Tan","orcid":"https://orcid.org/0009-0005-3648-6553","observed_orcids":["https://orcid.org/0009-0005-3648-6553"]},"institutions":[{"id":"https://openalex.org/I16835326","display_name":"University of St Andrews","ror":"https://ror.org/02wn5qz54","country_code":"GB","type":"education","lineage":["https://openalex.org/I16835326"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joecelyn Kirani Tan","raw_affiliation_strings":["School of Medicine, University of St. Andrews,\u00a0North Haugh, Fife,\u00a0Scotland KY16 9TF,\u00a0UK","St Andrews Oncology Society,\u00a0St Mary's Place,\u00a0Scotland KY16 9UZ,\u00a0UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of St. Andrews,\u00a0North Haugh, Fife,\u00a0Scotland KY16 9TF,\u00a0UK","institution_ids":["https://openalex.org/I16835326"]},{"raw_affiliation_string":"St Andrews Oncology Society,\u00a0St Mary's Place,\u00a0Scotland KY16 9UZ,\u00a0UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080393025","display_name":"Vasileios P Papadopoulos","orcid":"https://orcid.org/0000-0002-4188-9518","observed_orcids":["https://orcid.org/0000-0002-4188-9518"]},"institutions":[{"id":"https://openalex.org/I4210119880","display_name":"Kent and Canterbury Hospital","ror":"https://ror.org/02p23ar50","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802726858","https://openalex.org/I4210119880"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Vasileios Papadopoulos","raw_affiliation_strings":["Kent and Canterbury Hospital,\u00a0Ethelbert Road,\u00a0Canterbury CT1 3NG,\u00a0UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kent and Canterbury Hospital,\u00a0Ethelbert Road,\u00a0Canterbury CT1 3NG,\u00a0UK","institution_ids":["https://openalex.org/I4210119880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111042630","display_name":"Elisabet Sanchez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104168","display_name":"Medway NHS Foundation Trust","ror":"https://ror.org/01apxt611","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104168"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elisabet Sanchez","raw_affiliation_strings":["Department of Medical Oncology, Medway NHS Foundation Trust,\u00a0Windmill Road,\u00a0Gillingham ME7 5NY,\u00a0UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Medway NHS Foundation Trust,\u00a0Windmill Road,\u00a0Gillingham ME7 5NY,\u00a0UK","institution_ids":["https://openalex.org/I4210104168"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057565228","display_name":"Stergios Boussios","orcid":"https://orcid.org/0000-0002-2512-6131","observed_orcids":["https://orcid.org/0000-0002-2512-6131"]},"institutions":[{"id":"https://openalex.org/I119474363","display_name":"Canterbury Christ Church University","ror":"https://ror.org/0489ggv38","country_code":"GB","type":"education","lineage":["https://openalex.org/I119474363"]},{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I20581793","display_name":"University of Kent","ror":"https://ror.org/00xkeyj56","country_code":"GB","type":"education","lineage":["https://openalex.org/I20581793"]},{"id":"https://openalex.org/I4210104168","display_name":"Medway NHS Foundation Trust","ror":"https://ror.org/01apxt611","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104168"]},{"id":"https://openalex.org/I4387152671","display_name":"Kent and Medway Medical School","ror":"https://ror.org/049p9j193","country_code":"GB","type":"education","lineage":["https://openalex.org/I119474363","https://openalex.org/I20581793","https://openalex.org/I4387152671"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Stergios Boussios","raw_affiliation_strings":["AELIA Organization,\u00a09th Km Thessaloniki - Thermi,\u00a0Thessaloniki 57001,\u00a0Greece","Department of Medical Oncology, Medway NHS Foundation Trust,\u00a0Windmill Road,\u00a0Gillingham ME7 5NY,\u00a0UK","Faculty of Medicine, Health, and Social Care, Canterbury Christ Church University,\u00a0Canterbury CT2 7PB,\u00a0UK","Kent Medway Medical School, University of Kent,\u00a0Canterbury CT2 7LX,\u00a0UK","King's College London, Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences,\u00a0London SE1 9RT,\u00a0UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AELIA Organization,\u00a09th Km Thessaloniki - Thermi,\u00a0Thessaloniki 57001,\u00a0Greece","institution_ids":[]},{"raw_affiliation_string":"Department of Medical Oncology, Medway NHS Foundation Trust,\u00a0Windmill Road,\u00a0Gillingham ME7 5NY,\u00a0UK","institution_ids":["https://openalex.org/I4210104168"]},{"raw_affiliation_string":"Faculty of Medicine, Health, and Social Care, Canterbury Christ Church University,\u00a0Canterbury CT2 7PB,\u00a0UK","institution_ids":["https://openalex.org/I119474363"]},{"raw_affiliation_string":"Kent Medway Medical School, University of Kent,\u00a0Canterbury CT2 7LX,\u00a0UK","institution_ids":["https://openalex.org/I20581793","https://openalex.org/I4387152671"]},{"raw_affiliation_string":"King's College London, Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences,\u00a0London SE1 9RT,\u00a0UK","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5057565228"],"corresponding_institution_ids":["https://openalex.org/I119474363","https://openalex.org/I183935753","https://openalex.org/I20581793","https://openalex.org/I4210104168","https://openalex.org/I4387152671"],"apc_list":{"value":2230,"currency":"USD","value_usd":2230},"apc_paid":{"value":2230,"currency":"USD","value_usd":2230},"fwci":0.6678,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.59145221,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"13","issue":null,"first_page":"101732","last_page":"101732"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8939999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8939999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.10350000113248825,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12695","display_name":"Urinary and Genital Oncology Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9470000267028809},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.8450000286102295},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9079999923706055},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-toxicity","display_name":"immune checkpoint inhibitor toxicity","score":0.6200000047683716},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.7599999904632568},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.9660000205039978},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.5569999814033508},{"id":"https://openalex.org/keywords/cisplatin-ineligible-patients","display_name":"cisplatin-ineligible patients","score":0.8209999799728394},{"id":"https://openalex.org/keywords/intravesical-therapy","display_name":"intravesical therapy","score":0.6480000019073486},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-related-pneumonitis","display_name":"immune-related pneumonitis","score":0.6060000061988831},{"id":"https://openalex.org/keywords/immune-mediated-colitis","display_name":"immune-related colitis","score":0.8560000061988831},{"id":"https://openalex.org/keywords/immune-related-nephritis","display_name":"immune-related nephritis","score":0.5860000252723694},{"id":"https://openalex.org/keywords/immune-related-hepatitis","display_name":"immune-related hepatitis","score":0.40700000524520874}],"concepts":[{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.6526204943656921},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4529792070388794},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.41041749715805054},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4038694500923157},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3518970012664795},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26079484820365906},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2475350797176361}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.toxrep.2024.101732","doi":"https://doi.org/10.1016/j.toxrep.2024.101732","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.toxrep.2024.101732","pdf_url":null,"source":{"id":"https://openalex.org/S2764757124","display_name":"Toxicology Reports","issn_l":"2214-7500","issn":["2214-7500"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11420502","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11420502","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11420502/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicol Rep","raw_type":"Text"},{"id":"pmid:39318722","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39318722","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology reports","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:73559c60898241f786734171f0eca8d4","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/73559c60898241f786734171f0eca8d4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Toxicology Reports, Vol 13, Iss , Pp 101732- (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.toxrep.2024.101732","doi":"https://doi.org/10.1016/j.toxrep.2024.101732","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.toxrep.2024.101732","pdf_url":null,"source":{"id":"https://openalex.org/S2764757124","display_name":"Toxicology Reports","issn_l":"2214-7500","issn":["2214-7500"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320666","display_name":"University of Kent","ror":"https://ror.org/00xkeyj56"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4402436638.pdf","grobid_xml":"https://content.openalex.org/works/W4402436638.grobid-xml"},"referenced_works_count":59,"referenced_works":["https://openalex.org/W1966046397","https://openalex.org/W1971208896","https://openalex.org/W2084075250","https://openalex.org/W2124427232","https://openalex.org/W2151488185","https://openalex.org/W2159738538","https://openalex.org/W2166662937","https://openalex.org/W2233818050","https://openalex.org/W2289712604","https://openalex.org/W2293531514","https://openalex.org/W2413971556","https://openalex.org/W2530516001","https://openalex.org/W2559804019","https://openalex.org/W2582671354","https://openalex.org/W2588916311","https://openalex.org/W2672184770","https://openalex.org/W2745624257","https://openalex.org/W2760661635","https://openalex.org/W2777192533","https://openalex.org/W2887577080","https://openalex.org/W2888420686","https://openalex.org/W2903848939","https://openalex.org/W2947303998","https://openalex.org/W2987385271","https://openalex.org/W3004373987","https://openalex.org/W3007099934","https://openalex.org/W3011714452","https://openalex.org/W3015178699","https://openalex.org/W3024551702","https://openalex.org/W3034884095","https://openalex.org/W3036701611","https://openalex.org/W3048540526","https://openalex.org/W3087464965","https://openalex.org/W3087466624","https://openalex.org/W3128646645","https://openalex.org/W3134100188","https://openalex.org/W3145801579","https://openalex.org/W3152878368","https://openalex.org/W3163567195","https://openalex.org/W3163995648","https://openalex.org/W3164197656","https://openalex.org/W3164781831","https://openalex.org/W4200026971","https://openalex.org/W4281249833","https://openalex.org/W4306851590","https://openalex.org/W4310184597","https://openalex.org/W4320483202","https://openalex.org/W4322720171","https://openalex.org/W4323294881","https://openalex.org/W4379278560","https://openalex.org/W4379535548","https://openalex.org/W4380290766","https://openalex.org/W4383497640","https://openalex.org/W4386168112","https://openalex.org/W4386527022","https://openalex.org/W4387670137","https://openalex.org/W4392285003","https://openalex.org/W6773098960","https://openalex.org/W6775391015"],"related_works":["https://openalex.org/W4376879161","https://openalex.org/W3118442307","https://openalex.org/W4376135957","https://openalex.org/W2889892351","https://openalex.org/W3198753155","https://openalex.org/W7133699991","https://openalex.org/W2640284788","https://openalex.org/W4414559699","https://openalex.org/W2807693780","https://openalex.org/W4205103362"],"abstract_inverted_index":{"Bladder":[0],"cancer":[1,411],"is":[2,17,32,95,199,243,281],"the":[3,18,30,67,83,99,130,248,257,265,310,336,383,386],"tenth":[4],"most":[5,19],"prevalent":[6],"malignancy":[7],"worldwide,":[8],"with":[9,38,61,137,211,261,304,419,431],"a":[10,138,150,188,251,392],"significant":[11],"mortality":[12],"burden.":[13],"Urothelial":[14],"carcinoma":[15],"(UC)":[16],"common":[20],"histological":[21],"subtype,":[22],"and":[23,54,110,129,146,163,167,173,186,217,234,309,319],"treatment":[24,68,101,190,267,384,406,427],"options":[25],"are":[26,127,165],"guided":[27],"by":[28],"whether":[29],"disease":[31,415],"muscle-invasive":[33,432],"(MIBC)":[34],"or":[35,59,90,413],"non-muscle-invasive":[36],"(NMIBC),":[37],"subsequent":[39],"risk":[40,258,409],"group":[41],"stratification.":[42],"The":[43],"growing":[44],"popularity":[45],"of":[46,70,82,123,132,141,250,259,269,291,306,314,316,338,350,370,385],"immune":[47,332,371,372],"checkpoint":[48,373],"inhibitors":[49,374],"(ICIs)":[50,375],"to":[51,106,115,120,201,286,297,327,335],"treat":[52],"MIBC":[53],"NMIBC":[55,145],"as":[56,98,187,222,391,403],"either":[57],"monotherapy":[58],"combined":[60],"intravesical":[62,77,86],"agents,":[63],"may":[64,206],"radically":[65],"change":[66],"paradigm":[69],"UC.":[71],"Current":[72],"treatments":[73],"for":[74,102,153,171,192,382,395,425],"NMBIC":[75],"includes":[76],"chemotherapy":[78,94,421],"after":[79,414],"trans-urethral":[80],"resection":[81],"bladder":[84,295,378,387,433],"tumour,":[85],"bacillus":[87],"Calmette-Guerin":[88],"(BCG)":[89],"radical":[91],"cystectomy.":[92],"Cisplatin-based":[93],"widely":[96],"regarded":[97],"first-line":[100],"metastatic":[103,124,398],"UC":[104,125,194],"due":[105,334],"its":[107],"beneficial":[108],"response":[109],"survival":[111,140],"rates":[112],"when":[113],"compared":[114],"alternative":[116,152],"therapies.":[117],"However,":[118],"up":[119],"70":[121],"%":[122],"patients":[126,134,205,412,430],"ineligible,":[128],"prognosis":[131],"these":[133],"remains":[135],"poor,":[136],"median":[139],"13\u201316":[142],"months.":[143],"For":[144],"MIBC,":[147],"ICIs":[148,158,270],"provide":[149,287],"promising":[151,176],"cisplatin-ineligible":[154],"patients.":[155,422],"In":[156],"UC,":[157],"including":[159],"atezolizumab,":[160],"nivolumab,":[161],"avelumab,":[162],"pembrolizumab":[164],"Food":[166],"Drug":[168],"Administration":[169],"(FDA)-approved":[170],"monotherapy,":[172],"have":[174],"demonstrated":[175],"results,":[177],"particularly":[178],"in":[179,255,294,300,377,407,417,428],"those":[180],"who":[181],"cannot":[182],"receive":[183],"cisplatin-based":[184],"chemotherapy,":[185],"second-line":[189,426],"option":[191],"recurrent":[193],"following":[195],"platinum-based":[196,420],"chemotherapy.":[197],"It":[198],"important":[200],"consider":[202],"that":[203],"some":[204],"experience":[207],"adverse":[208,324],"events":[209,325],"(AEs)":[210],"limited":[212],"clinical":[213,311],"benefit.":[214],"Infusion-related":[215],"reactions":[216],"immune-mediated":[218],"AEs":[219],"(imAEs)":[220],"such":[221],"colitis,":[223],"endocrinopathies,":[224],"hepatitis,":[225],"pneumonitis,":[226],"interstitial":[227],"lung":[228],"disease,":[229],"renal":[230],"dysfunction,":[231],"nephritis,":[232],"cutaneous":[233],"neurological":[235],"toxicities":[236,293,376],"must":[237],"be":[238],"monitored":[239],"for.":[240],"Currently,":[241],"there":[242],"no":[244],"clear":[245],"consensus":[246],"on":[247,264],"role":[249],"\u2018two-year":[252],"stopping":[253],"rule\u2019":[254],"reducing":[256],"imAEs,":[260],"further":[262],"research":[263],"optimal":[266],"duration":[268],"required.":[271],"With":[272],"increased":[273],"ICI":[274,292],"use,":[275],"vigilance":[276],"regarding":[277],"their":[278,301],"side":[279],"effects":[280],"imperative.":[282],"This":[283],"review":[284],"aims":[285],"an":[288,330,404],"updated":[289],"overview":[290],"cancer,":[296],"assist":[298],"clinicians":[299],"therapeutic":[302],"decision-making,":[303],"consideration":[305],"patient":[307],"characteristics":[308],"context.":[312],"Mechanism":[313],"action":[315],"anti":[317,320],"CTLA-4":[318],"PD-1/PD-L1":[321],"agents.":[322],"Immune-mediated":[323],"seem":[326],"result":[328],"from":[329],"exaggerated":[331],"response,":[333],"breakdown":[337],"immunological":[339],"self-tolerance.":[340],"TCR:":[341],"T-cell":[342],"receptor,":[343],"MHC:":[344],"major":[345],"histocompatibility":[346],"complex,":[347],"CD80/86:":[348],"cluster":[349],"differentiation":[351],"80/87,":[352],"PD1:":[353],"programmed":[354,360],"cell":[355],"death":[356],"protein":[357,366],"1,":[358],"PD-L1:":[359],"death-ligand,":[361],"CTLA-4:":[362],"cytotoxic":[363],"T-lymphocyte":[364],"associated":[365],"4":[367],"\u2022":[368,380,389,401,423],"Overview":[369],"cancer.":[379,388,400,434],"Atezolizumab":[381],"Avelumab":[390],"maintenance":[393],"therapy":[394],"locally":[396],"advanced,":[397],"urothelial":[399,410],"Nivolumab":[402],"adjuvant":[405],"high":[408],"progression":[416],"pre-treated":[418,429],"Pembrolizumab":[424]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2024-09-12T00:00:00"}